-
Top News: C&J Energy Services (NYSE:CJES), Regado Biosciences (NASDAQ:RGDO), Libbey Inc. (NYSEMKT:LBY), ZAGG Inc (NASDAQ:ZAGG), Ardelyx (NASDAQ:ARDX)
On January 27, the Delaware Supreme Court in C&J Energy Services, Inc. (NYSE:CJES), et al. v. City of Miami General Employees’ and Sanitation Employees’ Retirement Trust, No. 655/657 (“C & J Energy”) recently entered an order confirming that, even in a change of control situation, a board of directors does not need to actively shop…
-
Biotech Bullish Stocks: ImmunoGen (NASDAQ:IMGN), Spark Therapeutics (NASDAQ:ONCE), Biogen Idec Inc. (NASDAQ:BIIB), Regado Biosciences (NASDAQ:RGDO), CorMedix (NYSEMKT:CRMD)
For the Company’s quarter ended December 31, 2014 (2Q, FY2015), ImmunoGen Inc. (NASDAQ:IMGN) reported net income of $13.6 million, or $0.16 per basic and diluted share, compared to net income of $3.8 million, or $0.04 per basic and diluted share, for the same quarter last year (2Q, FY2014). On Friday shares of ImmunoGen, Inc. (NASDAQ:IMGN)…
-
Morning Alert: PulteGroup (NYSE:PHM), Regado Biosciences (NASDAQ:RGDO), VIVUS Inc. (NASDAQ:VVUS), Cresud S.A.C.I.F. y A. (ADR) (NASDAQ:CRESY), Haemonetics Corporation (NYSE:HAE)
PulteGroup, Inc. (NYSE:PHM) reported stronger-than-expected results for the fourth quarter. The Atlanta, Georgia-based company posted a quarterly profit of $217.1 million, or $0.58 per share, versus a year-ago profit of $220.1 million, or $0.57 per share. According to the press release, the latest quarter included $0.16 per share of tax and insurance benefits, offset by…
-
Moving Stocks: Regado Biosciences (NASDAQ:RGDO), Chanticleer Holdings (NASDAQ:HOTR), LivePerson Inc. (NASDAQ:LPSN), Pandora Media Inc (NYSE:P), Google Inc (NASDAQ:GOOGL)
On January 15, Regado Biosciences, Inc. (NASDAQ:RGDO) announced that it has entered into a definitive merger agreement with privately-held Tobira Therapeutics, Inc. As per the agreement, Tobira will merge with a wholly-owned subsidiary of Regado in an all-stock transaction, and form a company focused on the development of novel treatments for liver and inflammatory diseases.…
-
Market Alert: Regado Biosciences (NASDAQ:RGDO), QAD Inc. (NASDAQ:QADA), American Campus Communities (NYSE:ACC), Grand Canyon Education (NASDAQ:LOPE), Gol Linhas Aereas Inteligentes (NYSE:GOL)
Regado Biosciences, Inc. (NASDAQ:RGDO) and Tobira Therapeutics, Inc. announced that they have entered into a definitive agreement under which privately-held Tobira will merge with a wholly-owned subsidiary of Regado in an all-stock transaction. On Wednesday shares of Regado Biosciences, Inc. (NASDAQ:RGDO) closed at $1.01. QAD Inc. (NASDAQ:QADA) a leading provider of enterprise software and services…
-
Stocks Getting Hot: Regado Biosciences (NASDAQ:RGDO), MetLife (NYSE:MET), Infinity Property and Casualty Corp. (NASDAQ:IPCC), IberiaBank Corp. (NASDAQ:IBKC), OFG Bancorp (NYSE:OFG)
As many as 2 brokerage firms have rated Regado Biosciences Inc (NASDAQ:RGDO) at 4. Research Analysts at Zacks have ranked the company at 1, suggesting the traders with a rating of Outperform. 1 analysts have advised that investors exit the counter and rated it as strong sell. The stock garnered a place in the hold…
-
Hot Biotech Movers: Gilead Sciences Inc. (NASDAQ:GILD), ZIOPHARM Oncology (NASDAQ:ZIOP), Arena Pharmaceuticals (NASDAQ:ARNA), NPS Pharmaceuticals (NASDAQ:NPSP), Regado Biosciences (NASDAQ:RGDO)
Gilead Sciences (NASDAQ:GILD) saw a large drop in short interest in December. As of December 31st, there was short interest totalling 52,853,940 shares, a drop of 4.7% from the December 15th total of 55,467,752 shares, AnalystRatings.NET reports. On Wednesday shares of Gilead Sciences Inc. (NASDAQ:GILD) closed at $99.26. Company’s sales growth for last 5 years…
-
Hot Biotech Losers: BIND Therapeutics (NASDAQ:BIND), Regado Biosciences (NASDAQ:RGDO), Applied DNA Sciences Inc. (NASDAQ:APDN), Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)
BIND Therapeutics, Inc. (NASDAQ:BIND) , a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced that Scott Minick, BIND’s President and CEO, is scheduled to present at the Oppenheimer 25th Annual Healthcare Conference in New York on Thursday, December 11, 2014 at 3:55 p.m. EST. BIND Therapeutics, Inc. (NASDAQ:BIND) in last trading…
-
Biotech Stocks Touched New Lows: Rock Creek Pharmaceuticals (NASDAQ:RCPI), Medgenics (NYSEMKT:MDGN), BIND Therapeutics (NASDAQ:BIND), NeuroDerm (NASDAQ:NDRM), Regado Biosciences (NASDAQ:RGDO)
Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) on Nov. 10 announced its financial results for the third quarter ended September 30, 2014 and provided a business update. The Company recorded a net loss of approximately $10.0 million for the three months ended September 30, 2014, compared to a net loss of approximately $3.4 million for the same…
-
Why Making Dramatic Moves: Regado Biosciences (NASDAQ:RGDO), Sapient Corp. (NASDAQ:SAPE), First Internet Bancorp (NASDAQ:INBK), International Business Machines (NYSE:IBM), NPS Pharmaceuticals (NASDAQ:NPSP)
Regado Biosciences, Inc. (Nasdaq:RGDO), announced that it will hold a conference call and live audio webcast on Thursday, November 6, 2014, at 8:30 a.m. EST to discuss its third quarter 2014 financial results. Regado Biosciences, Inc. (NASDAQ:RGDO) in last trading activity fell -0.96% to close at $1.03. Company weekly performance is -2.83% while its quarterly…